China Medtech Joint Ventures – Ordeal Or Adventure? Part 1
This article was originally published in PharmAsia News
Executive Summary
Setting up a joint venture with a Chinese partner offers one access route. In the first of a two-part feature looking at companies’ experiences breaking into China, Clinica’s Tina Tan speaks to Raymond Akers, executive chairman of Akers Biosciences, to learn about his journey to signing a deal with a Chinese JV partner and the challenges he faced.